Patent details

EP4019019 Title: USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS

Basic Information

Publication number:
EP4019019
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP212072466
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS
French Title of Invention:
UTILISATION DE RILUZOLE, PROMÉDICAMENTS DE RILUZOLE OU ANALOGUES DE RILUZOLE AVEC IMMUNOTHÉRAPIES POUR TRAITER DES CANCERS
German Title of Invention:
VERWENDUNG VON RILUZOL, RILUZOLPRODRUGS ODER RILUZOLANALOGA MIT IMMUNTHERAPIEN ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
19/05/2017
Grant date:
07/02/2024
EP Publication Date:
29/06/2022
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/02/2024
EP B1 Publication Date:
07/02/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
19/05/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/03/2024
 
 

Name:
Biohaven Therapeutics Ltd.
Address:
215 Church Street, New Haven, CT 06510, United States (US)

History of Owners

From:
31/01/2024
To:
15/03/2024

Name:
Biohaven Pharmaceutical Holding Company Ltd.
Address:
234 Church Street Suite 301, New Haven, CT 06520, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
06/05/2024
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

Name:
CORIC, Vladimir
Address:
United States (US)

Priority

Priority Number:
201662339433 P
Priority Date:
20/05/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/428; C07D 277/82; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202406
Publication date:
07/02/2024
Description:
Grant (B1)

2

Issue number:
202416
Publication date:
17/04/2024
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/05/2025
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
06/05/2024 Power Of Attorney 1
07/05/2024 Outgoing Correspondence 1